Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kristine Allin MD, PhD

Kristine Højgaard Allin MD, PhD

Associate Professor, Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Department of Clinical Medicine, Aalborg University, Copenhagen, Denmark, and Department of Gastroenterology & Hepatology, Aalborg University Hospital, Aalborg, Denmark

Kristine Højgaard Allin, MD, PhD, is Associate Professor and Center Partner, the National Center of Excellence for Molecular Prediction of Inflammatory Bowel Disease, PREDICT, Copenhagen, Denmark.

Dr. Allin combines clinical epidemiology and pharmaco-epidemiology to explore treatment response in inflammatory bowel disease (IBD) and cardiometabolic comorbidity of IBD. She is Board member of the Epidemiological Committee (EpiCom) of the European Crohn’s and Colitis Organization, ECCO and of the Danish Society for Pharmacoepidemiology.


Dr. Allin has no relevant disclosures.